Q. On my last few trips, I developed severe nasal allergies and runny nose while on the plane. It was uncomfortable and embarrassing. Other travelers may have thought I had a bad cold or something ...

When Sue Wolff is ready to start the journey, she draws the blinds to her windows overlooking Highway 89, converts her office ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Life Sciences’ shareholders voted to approve the strategic combination with Beckley Psytech Limited and the corporate redomiciliation at the ...

Long-term use of inhalers and nasal sprays, common for respiratory issues, may increase infection risks, a meta-analysis ...

Illicit drug overdoses and the deaths they cause are trending down this year, despite spikes in a handful of states, ...

Called Neffy, it offers a needle-free alternative to the EpiPen used by those at risk of potentially fatal anaphylaxis to ...

QOL agreed to buy Evoke for $11 a share in a deal expected to close by the end of the year. QOL said it will fund the transaction with cash on hand. Shares of Evoke have more than doubled to $10.70 ...

Some experts believe, with proper precautions—and when other treatments have failed—that ketamine-assisted psychotherapy can ...

Thirty EMS agencies across North Carolina are approved to administer the addiction medication buprenorphine in the field; ...

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 ...

An ER doctor reveals that using decongestants for cold symptoms carries risks that land people in the hospital each year.